These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34375646)

  • 1. Ischemic heart failure mortality is not predicted by cardiac insulin resistance but by diabetes per se and coronary flow reserve: A retrospective dynamic cardiac
    Luong TV; Pedersen MGB; Kjærulff MLBG; Madsen S; Lauritsen KM; Tolbod LP; Søndergaard E; Gormsen LC
    Metabolism; 2021 Oct; 123():154862. PubMed ID: 34375646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use of cardiac 18 F-FDG viability PET: a retrospective study of 44 patients undergoing post-test revascularization.
    Luong TV; Ebbehoj A; Kjaerulff MLG; Nielsen R; Nielsen PH; Christiansen EH; Tolbod LP; Søndergaard E; Gormsen LC
    Int J Cardiovasc Imaging; 2022 Nov; 38(11):2447-2458. PubMed ID: 36434332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin.
    Masi S; Lautamäki R; Guiducci L; Di Cecco P; Porciello C; Pardini S; Morales MA; Chubuchny V; Salvadori PA; Emdin M; Sironi AM; Knuuti J; Neglia D; Nuutila P; Ferrannini E; Iozzo P
    Diabetologia; 2012 Sep; 55(9):2494-500. PubMed ID: 22752026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An abbreviated hyperinsulinemic-euglycemic clamp results in similar myocardial glucose utilization in both diabetic and non-diabetic patients with ischemic cardiomyopathy.
    Fallavollita JA; Luisi AJ; Yun E; deKemp RA; Canty JM
    J Nucl Cardiol; 2010 Aug; 17(4):637-45. PubMed ID: 20387134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic performance of quantitative PET tools for stratification of patients with ischemic cardiomyopathy undergoing myocardial viability assessment.
    Santana CA; Faber TL; Soler-Peter M; Sanyal R; Esteves FP; Ornelas M; Folks RD; Verdes L; Santana LF; Candell-Riera J; Garcia EV
    Nucl Med Commun; 2008 Nov; 29(11):970-81. PubMed ID: 18836375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance.
    Iozzo P; Chareonthaitawee P; Dutka D; Betteridge DJ; Ferrannini E; Camici PG
    Diabetes; 2002 Oct; 51(10):3020-4. PubMed ID: 12351442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based
    Hu L; Qiu C; Wang X; Xu M; Shao X; Wang Y
    BMC Cardiovasc Disord; 2018 Oct; 18(1):203. PubMed ID: 30373519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse Mismatch Pattern in Cardiac 18F-FDG Viability PET/CT Is Not Associated With Poor Outcome of Revascularization: A Retrospective Outcome Study of 91 Patients With Heart Failure.
    Hansen AK; Gejl M; Bouchelouche K; Tolbod LP; Gormsen LC
    Clin Nucl Med; 2016 Oct; 41(10):e428-35. PubMed ID: 27488429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.
    Gormsen LC; Svart M; Thomsen HH; Søndergaard E; Vendelbo MH; Christensen N; Tolbod LP; Harms HJ; Nielsen R; Wiggers H; Jessen N; Hansen J; Bøtker HE; Møller N
    J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28242634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure patients with prediabetes and newly diagnosed diabetes display abnormalities in myocardial metabolism.
    Nielsen R; Jorsal A; Iversen P; Tolbod L; Bouchelouche K; Sørensen J; Harms HJ; Flyvbjerg A; Bøtker HE; Wiggers H
    J Nucl Cardiol; 2018 Feb; 25(1):169-176. PubMed ID: 27473218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between myocardial blood flow and fasting glucose metabolism in ischemic heart disease. Quantitative assessment by nitrogen-13 ammonia and fluorine-18 fluorodeoxyglucose positron emission tomography.
    Watanabe T; Okazaki O; Akutsu Y; Yamanaka H; Michihata T; Katagiri T; Harumi K
    Jpn Heart J; 1998 May; 39(3):275-85. PubMed ID: 9711179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes.
    Gejl M; Søndergaard HM; Stecher C; Bibby BM; Møller N; Bøtker HE; Hansen SB; Gjedde A; Rungby J; Brock B
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1165-9. PubMed ID: 22544917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low myocardial glucose uptake in Turner syndrome is unaffected by growth hormone: a randomized, placebo-controlled FDG-PET study.
    Trolle C; Hjerrild B; Mortensen KH; Knorr S; Søndergaard HM; Christiansen JS; Gravholt CH
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):133-40. PubMed ID: 25645325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial perfusion reserve after a PET-driven revascularization procedure: a strong prognostic factor.
    Slart RH; Zeebregts CJ; Hillege HL; de Sutter J; Dierckx RA; van Veldhuisen DJ; Zijlstra F; Tio RA
    J Nucl Med; 2011 Jun; 52(6):873-9. PubMed ID: 21571798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Quantitative Metrics From Positron Emission Tomography in Ischemic Heart Failure.
    Benz DC; Kaufmann PA; von Felten E; Benetos G; Rampidis G; Messerli M; Giannopoulos AA; Fuchs TA; Gräni C; Gebhard C; Pazhenkottil AP; Flammer AJ; Kaufmann PA; Buechel RR
    JACC Cardiovasc Imaging; 2021 Feb; 14(2):454-464. PubMed ID: 32771569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial pre-synaptic sympathetic function correlates with glucose uptake in the failing human heart.
    Mongillo M; John AS; Leccisotti L; Pennell DJ; Camici PG
    Eur J Nucl Med Mol Imaging; 2007 Aug; 34(8):1172-7. PubMed ID: 17294189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of type 2 diabetes on myocardial insulin sensitivity to glucose uptake and perfusion in patients with coronary artery disease.
    Søndergaard HM; Bøttcher M; Marie Madsen M; Schmitz O; Hansen SB; Nielsen TT; Bøtker HE
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4854-61. PubMed ID: 16984986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and predictors of ischemia and outcomes in outpatients with diabetes mellitus referred for single-photon emission computed tomography myocardial perfusion imaging.
    Bourque JM; Patel CA; Ali MM; Perez M; Watson DD; Beller GA
    Circ Cardiovasc Imaging; 2013 May; 6(3):466-77. PubMed ID: 23547172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of diabetes mellitus on prediction of clinical outcome after coronary revascularization by 18F-FDG SPECT in patients with ischemic left ventricular dysfunction.
    Schinkel AF; Poldermans D; Rizzello V; van Domburg RT; Valkema R; Elhendy A; Biagini E; Krenning EP; Simoons ML; Bax JJ
    J Nucl Med; 2006 Jan; 47(1):68-73. PubMed ID: 16391189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.